查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1584710

動物用藥品市場：按產品類型、動物類型、給藥方法、適應症、分銷管道、最終用戶 - 2025-2030 年全球預測

Veterinary Pharmaceuticals Market by Products (Drugs, Medicinal Feed, Vaccines), Animal Type (Companion Animals, Livestock Animals), Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年動物用藥品市場規模為374.6億美元，預計2024年將達到405.3億美元，複合年成長率為8.35%，預計到2030年將達到657.1億美元。

動物用藥品市場包括旨在確保動物健康和福利的疫苗、感染疾病和抗寄生蟲藥等多種產品。這些藥物的需求源於畜牧業產量的增加、寵物飼養的日益重要以及有效疾病控制的需求。應用範圍從伴同性動物（貓、狗）到牲畜（牛、豬），我們為獸醫醫院和線上藥局等最終用戶部門提供服務。該市場的主要成長要素包括獸醫研究的進步、寵物醫療保健支出的增加以及動物福利意識的提高。通用感染疾病的增加也刺激了對有效動物用藥品的需求。潛在的商機在於透過基因組學和診斷學的進步來擴展個人化寵物醫療。電子商務的興起也是一個有前途的途徑，提供便利和廣泛的市場覆蓋範圍。然而，新興市場的成長面臨阻礙市場滲透的挑戰，例如嚴格的法律規範、藥品開發高成本以及仿冒品問題。此外，缺乏熟練的獸醫專業人員可能會限制某些地區的成長。創新可能集中在生技藥品和先進疫苗的開發上，特別是為了解決新出現的健康威脅。提供遠端獸醫服務的數位平台也具有顯著成長的潛力，符合消費者對數位健康解決方案的偏好。市場本質上是動態的，其特點是快速的科學進步和不斷變化的消費者需求，凸顯了相關人員保持靈活性和適應能力的重要性。與科技公司合作獲得資料主導的見解或開拓新興市場地區的開拓市場可以為您帶來競爭優勢。企業也應投資建立強大的供應鏈網路，以降低風險並有效應對監管環境，從而實現穩定成長和強大的市場定位。

主要市場統計
基準年[2023] 374.6億美元
預測年份 [2024] 405.3億美元
預測年份 [2030] 657.1億美元
複合年成長率（%） 8.35%

市場動態：揭示快速發展的動物用藥品市場的關鍵市場洞察

供需的動態交互作用正在改變動物用藥品市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 家畜和伴同性動物疾病發生率增加，對治療和藥物的需求增加
    • 增加獸醫保健領域的研發活動
  • 市場限制因素
    • 動物用藥品和疫苗相關回想風險
  • 市場機會
    • 新型、先進動物用藥品的開發
    • 企業加大投資擴大動物疫苗設施
  • 市場挑戰
    • 對動物疫苗副作用的擔憂

波特五力：駕馭動物用藥品市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解動物用藥品市場的外部影響

外部宏觀環境因素對動物用藥品市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解動物用藥品市場競爭狀況

動物用藥品市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣動物用藥品市場供應商的績效評估

FPNV定位矩陣是評估動物用藥品市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃動物用藥品市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對動物用藥品市場進行策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 牲畜和寵物疾病的發生率增加，對治療和藥物的需求增加
      • 增加獸醫保健領域的研發活動
    • 抑制因素
      • 與獸藥和疫苗相關的回想風險
    • 機會
      • 新型先進動物用藥品的開發
      • 企業加大投資擴建獸用疫苗設施
    • 任務
      • 對獸用疫苗副作用的擔憂
  • 市場區隔分析
    • 產品：對醫療飼料的需求不斷成長，以改善動物健康和生產力
    • 動物類型：由於疾病控制和生產力提高，牲畜對動物用藥品的需求增加
    • 服用方法：增加膠囊的利用率，確保劑量的準確性
    • 適應症：引入新的焦點來促進代謝紊亂的治療藥物
    • 分銷管道：由於便利且產品種類豐富，消費者對網路藥局的偏好日益增加
    • 最終使用者：擴大寵物飼主對動物用藥品的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章動物用藥品市場：依產品

  • 藥品
    • 止痛藥
    • 抗感染
      • 抗生素
      • 抗真菌藥物
    • 發炎藥
      • 非類固醇
      • 類固醇
    • 寄生劑
      • 外寄生蟲劑
      • 體內殺蟲劑
  • 藥飼料
    • 飼料中添加抗生素
    • 驅蟲飼料
    • 生長促進劑
    • 營養藥用飼料
    • 含有益生菌和益生元的藥用飼料
  • 疫苗
    • 去活化疫苗
    • 活病毒疫苗

第7章動物用藥品市場：依動物類型

  • 伴同性動物
    • 貓
    • 狗
    • 馬
  • 家畜
    • 牛
    • 家禽
    • 綿羊和山羊
    • 豬

第8章動物用藥品市場按管理方式

  • 可注射的
    • 肌肉注射
    • 皮下的
  • 口服
    • 膠囊
    • 液體懸浮液和糖漿
    • 藥片
  • 局部的
    • 奶油
    • 洗劑
    • 軟膏

第9章動物用藥品市場：依適應症分類

  • 慢性和急性疼痛管理
  • 免疫狀態
  • 感染疾病
  • 代謝紊亂
  • 神經系統疾病
  • 整形外科疾病
  • 寄生蟲感染疾病
  • 生殖健康

第10章動物用藥品市場：按分銷管道

  • 網路藥房
  • 零售藥房
  • 獸醫診所

第11章動物用藥品市場：依最終用戶分類

  • 動物農場
  • 寵物飼主
  • 動物醫院

第12章：美洲動物用藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太動物用藥品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章歐洲、中東和非洲動物用藥品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Decla Pharmaceuticals 收購 Invex 以加強獸醫治療產品組合
    • TechInvention 與波札那研究所合作徹底改變獸用疫苗生產
    • 默克動物保健推出革命性 RNA 顆粒犬流感疫苗
    • Hube Pharma 投資 7,200 萬歐元擴建獸用疫苗廠，以促進全球供應和創新
    • Billback 透過收購 Sasae 鞏固其在日本市場的地位
    • FDA 的核准加強了對心臟和呼吸系統疾病的獸醫治療
    • EVML 對全球獸藥可及性和抗菌素抗藥性緩解的影響
    • Zendal 和 CSIC 推出創新 Neoleash 疫苗來對抗犬利什曼原蟲症
    • 默克動物保健公司收購Elanco的海鮮業務以加強其水產養殖業務
    • 華騰藥業拓展業務，推出氟拉拉納和薩羅拉納，徹底改變動物用藥品
    • ENTOD Pharmaceuticals 以「FUR by ENTOD」類別進入獸藥市場
    • 印度免疫學有限公司 (IIL) 投資 70 億盧比在海德拉巴建造疫苗工廠，加速消滅牲畜疾病
    • Virvac 收購 Globion 股份，以擴大其在印度禽疫苗市場的影響力
    • 珀布賴特研究所和薩省大學 VIDO 進行策略合作，加強疫苗創新和疫情防範
  • 戰略分析和建議
    • 德克拉製藥公司
    • 碩騰股份有限公司
    • 塞瓦聖動物
    • 勃林格殷格翰

公司名單

  • Aurora Pharmaceutical, Inc.
  • Biogenesis Bago SA
  • Biovac Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Chanelle Pharma
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Laboratorio Drag Pharma Chile Invetec SA
  • Merck & Co., Inc.
  • Neogen Corporation
  • Norbrook Group
  • Phibro Animal Health Corporation
  • Teknofarma Srl
  • Vetoquinol Group
  • Vetpharma Animal Health SL by Insud Pharma SLU
  • Virbac SA
  • Zendal Group
  • Zoetis Inc.
Product Code: MRR-032F197B035E

The Veterinary Pharmaceuticals Market was valued at USD 37.46 billion in 2023, expected to reach USD 40.53 billion in 2024, and is projected to grow at a CAGR of 8.35%, to USD 65.71 billion by 2030.

The scope of the veterinary pharmaceuticals market encompasses a wide array of products including vaccines, anti-infectives, and parasiticides aimed at ensuring animal health and welfare. Necessity for these pharmaceuticals arises due to increasing livestock production, the rising importance of pet ownership, and the demand for efficacious disease control measures. Applications range from companion animals (cats, dogs) to livestock (cattle, swine), serving end-user sectors like veterinary hospitals and online pharmacies. Key growth factors in this market include advancements in veterinary research, rising pet healthcare expenditure, and increased awareness towards animal welfare. The increasing incidence of zoonotic diseases is also fuelling demand for effective veterinary medications. Potential opportunities lie in the expansion of personalized pet medicine, driven by advancements in genomics and diagnostics. The rise of e-commerce in veterinary pharmaceuticals is another promising avenue, offering convenience and wider market reach. However, market growth faces challenges, such as strict regulatory frameworks, high costs of drug development, and issues related to counterfeit products, which can hinder market penetration. Moreover, the shortage of skilled veterinary professionals may limit growth in certain regions. Innovation could focus on the development of biologics and advanced vaccines, especially for emerging health threats. Digital platforms providing tele-veterinary services could also see substantial growth, aligning with consumer preferences for digital health solutions. The market is inherently dynamic, marked by rapid scientific advancements and evolving consumer demands, highlighting the importance for stakeholders to stay agile and adaptive. Partnering with technology firms for data-driven insights or exploring underpenetrated markets in developing regions could provide competitive advantages. Companies should also invest in building a robust supply chain network to mitigate risks and navigate the regulatory landscape effectively, aiming for steady growth and resilient market positioning.

KEY MARKET STATISTICS
Base Year [2023] USD 37.46 billion
Estimated Year [2024] USD 40.53 billion
Forecast Year [2030] USD 65.71 billion
CAGR (%) 8.35%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Pharmaceuticals Market

The Veterinary Pharmaceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of diseases in livestock and companion animals, rising need for treatment and medications
    • Increase in R&D activities for veterinary healthcare
  • Market Restraints
    • Risk of recalls associated with veterinary drugs and vaccines
  • Market Opportunities
    • Development of new and advanced veterinary pharmaceuticals
    • Increasing investment by companies for the expansion of veterinary vaccine facilities
  • Market Challenges
    • Concerns associated with the adverse effects of veterinary vaccine

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Pharmaceuticals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Pharmaceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Pharmaceuticals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Pharmaceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Pharmaceuticals Market

A detailed market share analysis in the Veterinary Pharmaceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Pharmaceuticals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Pharmaceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Pharmaceuticals Market

A strategic analysis of the Veterinary Pharmaceuticals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Aurora Pharmaceutical, Inc., Biogenesis Bago S.A., Biovac Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma, China Animal Husbandry Industry Co., Ltd., Dechra Pharmaceuticals PLC, ECO Animal Health Group PLC, Elanco Animal Health Incorporated, Heska Corporation, Hester Biosciences Limited, Indian Immunologicals Ltd., Intas Pharmaceuticals Ltd., Laboratorio Drag Pharma Chile Invetec S.A., Merck & Co., Inc., Neogen Corporation, Norbrook Group, Phibro Animal Health Corporation, Teknofarma S.r.l., Vetoquinol Group, Vetpharma Animal Health S.L. by Insud Pharma S.L.U., Virbac S.A., Zendal Group, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Products, market is studied across Drugs, Medicinal Feed, and Vaccines. The Drugs is further studied across Analgesics, Anti-Infectives, Anti-Inflammatories, and Parasiticides. The Anti-Infectives is further studied across Antibiotics and Antifungals. The Anti-Inflammatories is further studied across Non-Steroidal and Steroidal. The Parasiticides is further studied across Ectoparasiticides and Endoparasiticides. The Medicinal Feed is further studied across Antibiotic Medicated Feed, Antiparasitic Medicated Feed, Growth Promoters, Nutritional Medicated Feed, and Probiotic & Prebiotic Medicated Feed. The Vaccines is further studied across Inactivated Vaccines and Live Vaccines.
  • Based on Animal Type, market is studied across Companion Animals and Livestock Animals. The Companion Animals is further studied across Cats, Dogs, and Horses. The Livestock Animals is further studied across Cattle, Poultry, Sheep & Goats, and Swine.
  • Based on Mode of Administration, market is studied across Injectable, Oral, and Topical. The Injectable is further studied across Intramuscular and Subcutaneous. The Oral is further studied across Capsules, Liquid Suspension & Syrup, and Tablets. The Topical is further studied across Creams, Lotions, and Ointments.
  • Based on Indications, market is studied across Chronic & Acute Pain Management, Immunological Conditions, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Orthopedic Disorders, Parasitic Infections, and Reproductive Health.
  • Based on Distribution Channel, market is studied across Online Pharmacies, Retail Pharmacies, and Veterinary Clinics.
  • Based on End User, market is studied across Animal Farms, Pet Owners, and Veterinary Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New Jersey, New York, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of diseases in livestock and companion animals, rising need for treatment and medications
      • 5.1.1.2. Increase in R&D activities for veterinary healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Risk of recalls associated with veterinary drugs and vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of new and advanced veterinary pharmaceuticals
      • 5.1.3.2. Increasing investment by companies for the expansion of veterinary vaccine facilities
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the adverse effects of veterinary vaccine
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Products: The growing demand for medicinal feed to improve animal health and productivity
    • 5.2.2. Animal Type: Growing need for veterinary pharmaceuticals in livestock animals owing to disease control and productivity enhancement
    • 5.2.3. Mode of Administration: Increasing utilization of capsules for ensuring dosage accuracy
    • 5.2.4. Indications: Emerging focus on the introduction of drugs advancing treatments for metabolic disorders
    • 5.2.5. Distribution Channel: Growing consumer preference for online pharmacies owing to their convenience and wide range of products
    • 5.2.6. End User: Expanding applications of veterinary pharmaceuticals by pet owners
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary Pharmaceuticals Market, by Products

  • 6.1. Introduction
  • 6.2. Drugs
    • 6.2.1. Analgesics
    • 6.2.2. Anti-Infectives
      • 6.2.2.1. Antibiotics
      • 6.2.2.2. Antifungals
    • 6.2.3. Anti-Inflammatories
      • 6.2.3.1. Non-Steroidal
      • 6.2.3.2. Steroidal
    • 6.2.4. Parasiticides
      • 6.2.4.1. Ectoparasiticides
      • 6.2.4.2. Endoparasiticides
  • 6.3. Medicinal Feed
    • 6.3.1. Antibiotic Medicated Feed
    • 6.3.2. Antiparasitic Medicated Feed
    • 6.3.3. Growth Promoters
    • 6.3.4. Nutritional Medicated Feed
    • 6.3.5. Probiotic & Prebiotic Medicated Feed
  • 6.4. Vaccines
    • 6.4.1. Inactivated Vaccines
    • 6.4.2. Live Vaccines

7. Veterinary Pharmaceuticals Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Companion Animals
    • 7.2.1. Cats
    • 7.2.2. Dogs
    • 7.2.3. Horses
  • 7.3. Livestock Animals
    • 7.3.1. Cattle
    • 7.3.2. Poultry
    • 7.3.3. Sheep & Goats
    • 7.3.4. Swine

8. Veterinary Pharmaceuticals Market, by Mode of Administration

  • 8.1. Introduction
  • 8.2. Injectable
    • 8.2.1. Intramuscular
    • 8.2.2. Subcutaneous
  • 8.3. Oral
    • 8.3.1. Capsules
    • 8.3.2. Liquid Suspension & Syrup
    • 8.3.3. Tablets
  • 8.4. Topical
    • 8.4.1. Creams
    • 8.4.2. Lotions
    • 8.4.3. Ointments

9. Veterinary Pharmaceuticals Market, by Indications

  • 9.1. Introduction
  • 9.2. Chronic & Acute Pain Management
  • 9.3. Immunological Conditions
  • 9.4. Infectious Diseases
  • 9.5. Metabolic Disorders
  • 9.6. Neurological Disorders
  • 9.7. Orthopedic Disorders
  • 9.8. Parasitic Infections
  • 9.9. Reproductive Health

10. Veterinary Pharmaceuticals Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Online Pharmacies
  • 10.3. Retail Pharmacies
  • 10.4. Veterinary Clinics

11. Veterinary Pharmaceuticals Market, by End User

  • 11.1. Introduction
  • 11.2. Animal Farms
  • 11.3. Pet Owners
  • 11.4. Veterinary Hospitals

12. Americas Veterinary Pharmaceuticals Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Veterinary Pharmaceuticals Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Veterinary Pharmaceuticals Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Dechra Pharmaceuticals to acquire Invetx to enhance veterinary therapeutics portfolio
    • 15.3.2. TechInvention and Botswana Institute partner to revolutionize veterinary vaccine production
    • 15.3.3. Merck Animal Health introduces innovative RNA-particle Canine Flu vaccine
    • 15.3.4. Huvepharma Expands with EUR 72 million veterinary vaccine plant to boost global supply and innovation
    • 15.3.5. Virbac strengthens position in Japanese market with Sasaeah acquisition
    • 15.3.6. FDA approvals enhance veterinary treatments for heart and respiratory conditions
    • 15.3.7. Impact of EVML on global veterinary medicine accessibility and AMR mitigation
    • 15.3.8. Zendal and CSIC unveil innovative Neoleish vaccine to combat canine leishmaniasis
    • 15.3.9. Merck Animal Health acquires Elanco's aqua business to strengthen aquaculture presence
    • 15.3.10. Huateng Pharma expands with fluralaner and sarolaner launch, revolutionizing veterinary pharmaceuticals
    • 15.3.11. ENTOD Pharmaceuticals expands into veterinary market with "FUR by ENTOD" division
    • 15.3.12. Indian Immunologicals Ltd (IIL) invests INR 700 crore in Hyderabad vaccine plant to boost livestock disease eradication
    • 15.3.13. Virbac acquires stake in Globion to boost avian vaccine market presence in India
    • 15.3.14. Strategic collaboration between Pirbright Institute and USask's VIDO to boost vaccine innovation and pandemic readiness
  • 15.4. Strategy Analysis & Recommendation
    • 15.4.1. Dechra Pharmaceuticals PLC
    • 15.4.2. Zoetis Inc.
    • 15.4.3. Ceva Sante Animale
    • 15.4.4. Boehringer Ingelheim GmbH

Companies Mentioned

  • 1. Aurora Pharmaceutical, Inc.
  • 2. Biogenesis Bago S.A.
  • 3. Biovac Ltd.
  • 4. Boehringer Ingelheim International GmbH
  • 5. Ceva Sante Animale
  • 6. Chanelle Pharma
  • 7. China Animal Husbandry Industry Co., Ltd.
  • 8. Dechra Pharmaceuticals PLC
  • 9. ECO Animal Health Group PLC
  • 10. Elanco Animal Health Incorporated
  • 11. Heska Corporation
  • 12. Hester Biosciences Limited
  • 13. Indian Immunologicals Ltd.
  • 14. Intas Pharmaceuticals Ltd.
  • 15. Laboratorio Drag Pharma Chile Invetec S.A.
  • 16. Merck & Co., Inc.
  • 17. Neogen Corporation
  • 18. Norbrook Group
  • 19. Phibro Animal Health Corporation
  • 20. Teknofarma S.r.l.
  • 21. Vetoquinol Group
  • 22. Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
  • 23. Virbac S.A.
  • 24. Zendal Group
  • 25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY PHARMACEUTICALS MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. VETERINARY PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. VETERINARY PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY PHARMACEUTICALS MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NON-STEROIDAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY STEROIDAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIPARASITIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROWTH PROMOTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NUTRITIONAL MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PROBIOTIC & PREBIOTIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIQUID SUSPENSION & SYRUP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CHRONIC & ACUTE PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY IMMUNOLOGICAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 83. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 84. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 85. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 87. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 88. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 90. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 91. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 92. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 93. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 98. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 99. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 100. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 101. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 102. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 103. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 105. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 106. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 108. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 109. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 110. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 114. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 115. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 116. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 117. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 118. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 119. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 120. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 122. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 123. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 125. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 126. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 127. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 131. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 132. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 133. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 134. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 135. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 136. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 137. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 139. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 140. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 142. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 143. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 144. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 145. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 148. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 149. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 150. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 151. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 152. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 153. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 154. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 156. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 157. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 159. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 160. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 161. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 162. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 165. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 166. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 167. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 168. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 169. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 170. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 171. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 173. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 174. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 176. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 177. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 200. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 201. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 202. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 203. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 204. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 205. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 206. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 207. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 209. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 210. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 212. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 213. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 214. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 215. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 218. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 219. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 220. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 221. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 222. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 223. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 224. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 226. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 227. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 229. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 230. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 231. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 232. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 235. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 236. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 237. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 238. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 239. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 240. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 241. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 243. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 244. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 245. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 246. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 247. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 248. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 249. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 250. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 252. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 253. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 254. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 255. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 256. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 257. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 258. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 260. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 261. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 262. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 263. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 264. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 265. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 266. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 267. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 268. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 269. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 270. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 271. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 272. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 273. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 274. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 275. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 277. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 278. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 280. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 281. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 282. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 283. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 284. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 285. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 286. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 287. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 288. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 289. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 290. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 291. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 292. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 294. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 295. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 296. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 297. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 298. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 299. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 300. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 301. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 303. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 304. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 305. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 306. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 307. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 308. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 309. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 311. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 312. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 313. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 314. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 315. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 316. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 317. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 318. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 319. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 320. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 321. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANT